U.S. FDA says it is working with global regulators to understand scope of cough syrup contamination


In a statement, the FDA said it had no indication that contaminated syrups had entered the U.S. drug supply chain, and it recommended consumers only take medicines which were made to be sold in the United States, especially for children.

Earlier this week, the WHO said it had expanded an inquiry into contaminated cough syrups linked to deaths in Gambia, Indonesia and Uzbekistan to four additional countries, and called on governments more widely to ensure that medicines for sale are approved by competent authorities.

Read More